PRNewsWire
24 Oct 2026, 02:00 UTC · 3h ago
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Impact · against what's priced in
The news is a non-event for HIMS as it serves as a procedural reminder for a legal situation the market has already discounted. The stock price already accounts for the FTC lawsuit and the resulting 14.73% decline from July 2026.
- HIMS+0.00
Already priced in
- The price assumes
Significant legal and regulatory friction, including FTC lawsuits over data privacy and billing practices.





